CAS: 16652-76-9; H-Val-Obzl.Tosoh

该化合物是将氨酸L-valine与苯甲基酯和磺酸盐组结合的化学化合物,该化合物通常具有氨酸和磺酸盐的特性,包括极地溶剂中的溶性以及潜在的生物活动.L-Valine是蛋白合成所需的亚氨酸链,并参与多种代谢过程.苯甲基酯的存在可能会增强脂性,影响其与生物膜的相互作用.4-甲基苯丙酸盐会增加溶性并增加稳定性,使该化合物适合于药物和生物化学的各种应用.其结构表明药物配方可能具有潜在用途,因为其可能用作一种药剂或一种稳定剂.

结构式图片

相似化合物

17662-84-9 16652-75-8 1738-77-8

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号72-18-4 l-缬氨酸 | CAS号104-15-4 对甲苯磺酸 | CAS号100-51-6 苯甲醇 | CAS号4070-48-8 L-缬氨酸甲酯 | CAS号21760-98-5 L-缬氨酸苄酯 | CAS号72-18-4 l-缬氨酸 | CAS号13588-95-9 (S)-2-((S)-2-氨基... | CAS号122299-14-3 eglin c (60-63) | CAS号3918-94-3 缬氨酰-缬氨酸

合成工艺路线路线简述

    N-(二苯基亚甲基)-L-缬氨酸甲酯置于sodium Hydroxide,四丁基硫酸氢铵体系中,用 水,乙腈 用作溶剂,化学反应 22.0H,反应生成L-缬氨酸苄酯对甲苯磺酸盐
    参考文献:Oxygen Alkylation Of Schiff Base Derivatives Of Amino Acids
    标题:Oxygen Alkylation Of Schiff Base Derivatives Of Amino Acids
    摘要:氨基酸和二肽的高亚胺酯1A-H和7A-B通过皂化苯甲酮席夫碱甲酯3A-D和6,采用相转移技术,随后与烷基卤进行o-烷基化,产率在68-91%之间.该过程在α-碳上保留构型,除了苯基甘氨酸衍生物外.
    Doi:10.1055/s-1991-26625

    海关参考信息

    专利信息


    专利号:EP-1831186-B1
    优先权日:2004-11-30
    标题:A process for the synthesis of valsartan
    发明人:ZUPANCIC SILVO; PECAVAR ANICA; ZUPET ROK
    权利人:KRKA D D NOVO MESTO
    摘要:This invention relates to an improved process for preparing a valsartan, or a pharmaceutically acceptable salt thereof, or pharmaceutical preparation containing either entity wherein a compound of formula (II) nor a salt thereof, is reacted with valine or an ester or a salt thereof in a solvent selected from the group consisting of methylene chloride, chloroform, butyl chloride, isopropyl acetate and tert -butyl methyl ether to form a compound of formula (IV) nwhich is then acylated to form a compound of formula (VI) nwherein R is hydrogen, alkyl, alkenyl or benzyl; which is then deprotected to give valsartan, and may be converted to a pharmaceutically acceptable salt and/or a pharmaceutical formulation. The invention also covers intermediates of formula (IV) and (VI) wherein R=H.

    专利号:WO-2006058701-A1
    优先权日:2004-11-30
    标题:A process for the synthesis of valsartan

    专利号:EP-1831186-A1
    优先权日:2004-11-30
    标题:A process for the synthesis of valsartan

    专利号:EP-1661891-A1
    优先权日:2004-11-30
    标 题 :A process for the synthesis of valsartan

    专利号:US-6858585-B1
    优先权日:1996-06-25
    标题 :Cyclic depsipeptides and drugs containing the same as the active ingredient
    发明人:YANAI MAKOTO; SUZUKI MASASHI; OSHIDA NORIO; KAWAMURA KOJI; HIRAMOTO SHIGERU; YASUDA ORIE; KINOSHITA NOBUHIRO; SHINGAI AKIKO; TAKASU MASAKO
    权利人:NISSHIN SEIFUN GROUP INC
    摘要:Cyclic depsipeptides represented by the formula n n nwherein:n n R is a straight or branched alkyl group of 5-20 carbon atoms or a straight or branched alkoxymethyl group of 5-15-carbon atoms; A, B, D, E and F independently each other are alanine, valine, leucine, isoleucine, phenylalanine, etc.; W and Z independently each other are aspartic acid, asparagine, glutamic acid or glutamine; and m and n independently each other is 0 or 1, or pharmacologically acceptable salts thereof. The present compounds are prepared according to a method conventionally used in peptide synthesis. The present compounds are useful as an agent for promoting the production of apolipoprotein E, a therapeutic agent for neurologic damages, a therapeutic agent for dementia, an agent for inhibiting the production of apolipoprotein B, an agent for promoting the production of apolipoprotein A1 or a therapeutic agent for hyperlipemia.

    专利号:CN-102241674-A
    优先权日:2010-05-12
    标题 :Synthesis and Antitumor Activity Evaluation of 1,1-Dimethyl-β-carboline-3-formyl Amino Acid Benzyl Ester
    成都悦康科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yuekangtech.com
    电话: 0086 (28) 8669-1469👤
    📞成都悦康科技有限公司 ⚠️参考联系方式

    销售电话:0086 (28) 8669-1469
    邮箱:richard@yuekangtech.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    合成方法参考DOI号:10.1055/s-1991-26625
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知